Amisha Singapuri

The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma

Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease

DP ₂ antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment

Fevipiprant, a prostaglandin D 2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial